Cargando…

ZMIZ2 promotes the development of triple-receptor negative breast cancer

BACKGROUND: Triple-receptor negative breast cancer (TNBC) is an aggressive breast tumor subtype that generally has a poor prognosis. This study aimed to investigate the role and regulatory mechanisms of Zinc finger MIZ-type containing 2 (ZMIZ2) in relation to TNBC. METHODS: Based on data from The Ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Xiaopan, Liu, Yan, Di, Jun, Wei, Wei, Watanabe, Nobumoto, Li, Jiang, Li, Xiaomeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802436/ https://www.ncbi.nlm.nih.gov/pubmed/35101047 http://dx.doi.org/10.1186/s12935-021-02393-x

Ejemplares similares

ZMIZ1 promotes the proliferation and migration of melanocytes in vitiligo
por: Li, Meng, et al.
Publicado: (2020)

ZMIZ1 Preferably Enhances the Transcriptional Activity of Androgen Receptor with Short Polyglutamine Tract
por: Li, Xiaomeng, et al.
Publicado: (2011)

Roles of eIF3m in the tumorigenesis of triple negative breast cancer
por: Han, Wei, et al.
Publicado: (2020)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
por: Li, Yang, et al.
Publicado: (2020)

MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
por: Weihua, Zeng, et al.
Publicado: (2020)

LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
por: Lv, Jianxin, et al.
Publicado: (2020)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
por: Yang, Zhi-Xue, et al.
Publicado: (2018)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer
por: Huang, Yajing, et al.
Publicado: (2020)

EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
por: Zhang, Ruishan, et al.
Publicado: (2020)

LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis
por: Li, Peng, et al.
Publicado: (2022)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
por: Liu, Weiguang, et al.
Publicado: (2019)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis
por: Fewings, N., et al.
Publicado: (2017)

Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
por: Xi, Yue, et al.
Publicado: (2022)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
por: Zhang, Purong, et al.
Publicado: (2020)

PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
por: Li, Zheng, et al.
Publicado: (2021)

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
por: Yi, Dandan, et al.
Publicado: (2019)

SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression
por: Wang, Lu, et al.
Publicado: (2013)

Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition
por: Elango, Ramesh, et al.
Publicado: (2021)

Common variants in ZMIZ1 and near NGF confer risk for primary dysmenorrhoea
por: Li, Zhiqiang, et al.
Publicado: (2017)

Ceramide kinase mediates intrinsic resistance and inferior response to chemotherapy in triple‐negative breast cancer by upregulating Ras/ERK and PI3K/Akt pathways
por: Zhu, Shan, et al.
Publicado: (2021)

Suboptimal concordance in testing and retesting results of triple-negative breast carcinoma cases among laboratories: one institution experience
por: De Jesus, Jose, et al.
Publicado: (2019)

LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple‐negative breast cancer by sponging miR-6504-5p and miR-3139
por: Luo, Xiao, et al.
Publicado: (2021)

Circular RNA hsa_circ_0044234 as distinct molecular signature of triple negative breast cancer: a potential regulator of GATA3
por: Darbeheshti, Farzaneh, et al.
Publicado: (2021)

Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis
por: Chen, Fei-Yu, et al.
Publicado: (2020)

ADAM10 is involved in the oncogenic process and chemo-resistance of triple-negative breast cancer via regulating Notch1 signaling pathway, CD44 and PrPc
por: Cheng, Yuanyuan, et al.
Publicado: (2021)

CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis
por: Dou, Dongwei, et al.
Publicado: (2020)

Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3
por: Fang, Xuan, et al.
Publicado: (2020)

Prostate Cancer Susceptibility Loci Identified in GATA2 and ZMIZ1 in Chinese Population
por: Zhang, Hui-Jing, et al.
Publicado: (2022)

Zmiz1 is a novel regulator of lymphatic endothelial cell gene expression and function
por: Rajan, K C, et al.
Publicado: (2023)

miR-639 promotes the proliferation and invasion of breast cancer cell in vitro
por: Li, Lin, et al.
Publicado: (2014)

TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p
por: Pei, Jing, et al.
Publicado: (2019)

EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer
por: Wu, Dongbo, et al.
Publicado: (2020)

TMED3/RPS15A Axis promotes the development and progression of osteosarcoma
por: Xu, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dabevmr5hr1d9j6l27b23fikjq